On December 31, the Joint Prevention and Control Mechanism of the State Council was released. Sinopharm's China Bio-New Crown Inactivated Vaccine has been approved by the State Food and Drug Administration for conditional listing.

  So far, 14 vaccines have been approved to enter clinical trials, and 5 of them are undergoing phase III clinical trials, including the newly-announced new coronavirus inactivated vaccine of Sinopharm Beijing Company, and a batch of pre-clinical drugs are accelerating Advance.

  (Edit Zhou Jing)

Editor in charge: [Li Ji]